US2005239135A1PendingUtilityA1
Compositions, methods and kits for biarsenical fluorophore labeling
Individually held — no corporate assignee on recordPriority: Oct 24, 2003Filed: Oct 22, 2004Published: Oct 27, 2005
Est. expiryOct 24, 2023(expired)· nominal 20-yr term from priority
C07K 1/13C12Y 302/01014G01N 33/533C12Y 302/01031C12N 9/1033Y10T436/13C12N 9/2442Y10T436/18Y10T436/105831Y10T436/25
60
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Methods, compositions, and kits for labeling tetracysteine-tagged proteins with biarsenical fluorophores with increased specificity, including compositions, methods and kits particularly adapted for labeling of tetracysteine-tagged proteins to be resolved within an electrophoresis gel.
Claims
exact text as granted — not AI-modified1 . A method of labeling a tetracysteine-tagged protein species present in a protein sample with a biarsenical fluorophore, the method comprising:
treating the proteins in said sample in the presence of a composition comprising a thiol competitor and a biarsenical fluorophore.
2 . The method of claim 1 , wherein said composition further comprises a reducing agent.
3 . The method of claim 2 , wherein said reducing agent is tributylphosphine (TBP).
4 . The method of claim 1 , wherein said thiol competitor is a monothiol.
5 . The method of claim 4 , wherein said monothiol is beta-mercaptoethanol (BME) and the BME is at a concentration greater than about 1 mM.
6 . The method of claim 5 , wherein said BME is at a concentration of at least about 5 mM.
7 . The method of claim 6 , wherein said BME is at a concentration of at least about 60 mM.
8 . The method of claim 1 , wherein said thiol competitor is a dithiol with concentration of at least 100 μM.
9 . (canceled)
10 . The method of claim 2 , wherein said reducing agent is at a concentration of at least about 1 mM.
11 - 12 . (canceled)
13 . The method of claim 1 , wherein said biarsenical fluorophore is a biarsenical derivative of fluorescein.
14 . The method of claim 13 , wherein said biarsenical fluorophore is 4′-5′-bis(1,3,2-dithioarsolan-2-yl)fluorescein-(2,2-ethanedithiol)2.
15 . (canceled)
16 . The method of claim 2 , wherein said biarsenical fluorophore is added to said protein sample after said thiol competitor and said reducing agent are added.
17 - 19 . (canceled)
20 . The method of claim 16 , wherein said treating step is at a temperature of about 70° C.
21 - 24 . (canceled)
25 . The method of claim 1 , wherein said treating is for a period of no more than about 10 minutes.
26 . The method of claim 1 , further comprising a later step of:
resolving the proteins in said sample by gel electrophoresis.
27 . The method of claim 26 , comprising a yet further step of detecting said tetracysteine-tagged protein among said resolved proteins in said gel.
28 . The method of claim 1 , further comprising a later step of:
treating said protein sample with a thiol-blocking reagent.
29 . The method of claim 28 , wherein said thiol-blocking reagent is selected from the group consisting of: alkylhalides, iodoacetamide, iodoacetic acid, dithiobis(2-nitrobenzoic acid) (DTNB), dithiobis(5-nitropyridine), maleimide and ethylenemaleimide.
30 . (canceled)
31 . The method of claim 29 , wherein said thiol-blocking reagent is maleimide.
32 - 39 . (canceled)
40 . The method of claim 1 , wherein said biarsenical fluorophore is bonded to a surface of a support.
41 . The method of claim 40 , wherein said support comprises a plurality of beads.
42 - 47 . (canceled)
48 . A composition for improving specificity of labeling of tetracysteine-tagged proteins with a biarsenical fluorophore, comprising:
a biarsenical fluorophore; and a thiol competitor.
49 . The composition of claim 48 further comprising a reducing agent, wherein said reducing agent is tributylphosphine (TBP).
50 . The composition of claim 48 , wherein said thiol competitor is a mono- or dithiol.
51 . The composition of claim 50 , wherein said thiol competitor is beta-mercaptoethanol (BME).
52 . A kit for labeling tetracysteine-tagged proteins with a biarsenical fluorophore, comprising:
a first composition comprising a thiol competitor.
53 . The kit of claim 52 , wherein said first composition further comprises a biarsenical fluorophore.
54 . The kit of claim 52 , further comprising a second composition comprising a biarsenical fluorophore.
55 . The kit of claim 52 , further comprising:
a composition comprising a blocking reagent.
56 . The kit of claim 52 , wherein said thiol competitor is a mono- or dithiol.
57 . The kit of claim 56 , wherein said thiol competitor is beta-mercaptoethanol (BME).
58 . The kit of claim 52 , wherein said first composition further comprises a reducing agent, wherein said reducing agent is a phosphine.
59 . The kit of claim 58 , wherein said phosphine is tributylphosphine (TBP).
60 . The kit of claim 52 , wherein said biarsenical fluorophore is a biarsenical fluorescein derivative.
61 . (canceled)
62 . The kit of claim 55 , wherein said blocking reagent is selected from maleimide and iodoacetamide.
63 . The kit of claim 62 , where said blocking reagent is maleimide.
64 - 67 . (canceled)
68 . The composition of claim 48 further comprising at least one buffer, an ionic detergent, and a marker dye.
69 . The composition of claim 68 , wherein the buffer comprises Tris and EDTA; and the ionic detergent is a dodecylsulfate salt.Join the waitlist — get patent alerts
Track US2005239135A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.